Add the specialty areas of your choice to tailor excemed.org to your professional interests.
Save & Create free account
No thanks, just apply selection
I already have an account. Login

User login

We offer our registered users tailored information, free online courses and exclusive content.

You have an old EXCEMED account ...

Our platform has been renewed. All users registered at any of the old websites are kindly requested to reset their password. Why is this?

... or you lost your password?

Advisory Committee

The EXCEMED Advisory Committee supports the Board of Directors and the International Scientific Committee in its activities working on special projects. The Advisory Committee is composed of internationally acknowledged experts working in different fields of scientific interest.

Fortunato Ciardiello

Fortunato CiardielloFortunato Ciardiello is from the Seconda Universita di Napoli, Naples, Italy. Professor Ciardiello heads the University's Division of Medical Oncology and the Laboratory of Experimental Therapeutics and has recently been nominated as President of the European Society of Medical Oncology 2016-17.

Dr Ciardiello received his MD degree, his specialty training in medical oncology and his PhD degree in molecular biology and pathology from the University of Naples, Italy. He obtained research training for almost 5 years at the National Cancer Institute, NIH, Bethesda, MD, USA.

Dr Ciardiello received the “G. Venosta” Award from the Italian Foundation for Cancer Research (FIRC) in November 2000 for research on novel therapeutic strategies in cancer. Dr Ciardiello’s research interests involve the role of growth factors and their specific receptors in neoplastic transformation and the development of novel therapeutic strategies targeting growth factor receptor signaling, and he has published over 110 original research articles in these areas. In addition, Dr Ciardiello is an active member of several international scientific societies, including AACR, ASCO and ESMO, and serves on the editorial boards of the journals Clinical Cancer Research, Oncology Reports, International Journal of Oncology, and Signal: The Journal of the EGFR-Targeted Cancer Therapy.

 

Massimo Filippi

massimo_filippiMassimo Filippi graduated  in Medicine in 1986 followed by a Post-Degree graduation in Neurology in 1990. His research focuses on the use of MRI technology to improve our understanding of how neurological diseases determine progressive accumulation of irreversible physical disability and cognitive impairment. He has also coordinated several international clinical trials in multiple sclerosis. He is currently Associate Professor of Neurology at Università Vita-Salute San Raffaele, Director of the Interdepartmental Research Programme “BrainMap”, and Director of the Neuroimaging Research Unit, Institute of Experimental Neurology, Division of Neuroscience, San Raffaele Scientific Institute, Milan, Italy.He is member of various Scientific Societies and, in some of them, he covered or is covering institutional roles. He is also Editor in Chief of the Journal of Neurology and member of the Editorial Boards of many international scientific journals. He is author or co-author of more than 700 scientific papers published on peer-reviewed journals (H index: 76) and edited several international volumes. Prof. Filippi also received the "Rita Levi Montalcini Award" for his research work in multiple sclerosis.

 

 

Carlos Simón

Carlos SimonCarlos Simon is a board-certified and full Professor of Obstetrics and Gynecology at the University of Valencia, Valencia, Spain, and Scientific Director of both the Fundación IVI and the Prince Felipe Research Center, Valencia. Since 1991, his basic and clinical research has contributed to the advance of reproductive medicine, specifically in the understanding of human endometrialreceptivity, embryo viability, embryonic implantation and endometriosis. Since 2001, he has expanded his research into the field of stem cells, resulting in the derivation, characterization and registration in the Spanish National Stem Cell Bank (BNLC) of 10 human embryonic stem cell lines.

As Principal Investigator, his work has been funded through 10 projects sponsored by the Spanish Government, five by the Valencian Government, including a PROMETEO (granted to prestigious scientists), and 14 projects by international organizations, American universities and private companies.He has been the Director for 17 doctorates, all of whom qualified with cum laude, including four PhD awards of excellence and one European PhD. As inventor, his research has originated 11 patent applications, leading to the creation of three Biotechnology companies (iGenomix, Embryomics and Stemlifeline). He has published a total of 264 papers in international peer-review journals and is an Editor of 14 books.